Jan 29 (Reuters) - AstraZeneca PLC:
* CO’S COVID-19 VACCINE BEEN GRANTED CONDITIONAL MARKETING AUTHORISATION IN EUROPEAN UNION FOR ACTIVE IMMUNISATION
* WORKING WITH EU FOLLOWING APPROVAL OF A CMA FOR ACTIVE IMMUNISATION TO BEGIN ACROSS MEMBER STATES
* SEEKING EMERGENCY USE LISTING FROM WORLD HEALTH ORGANIZATION FOR ACCELERATED VACCINE AVAILABILITY IN LOW-INCOME COUNTRIES
* ADDITIONAL SAFETY EFFICACY DATA FOR VACCINE TO CONTINUE TO ACCUMULATE FROM ONGOING TRIALS; EXPECTED TO BE PUBLISHED IN COMING WEEKS
* ASTRAZENECA IS CONDUCTING A LARGE TRIAL IN US AND GLOBALLY
* OXFORD UNIVERSITY AND ASTRAZENECA EXPECT TO ENROL UP TO 60,000 PARTICIPANTS GLOBALLY Source text for Eikon: Further company coverage:

Source: Reuters

Powered by NewsAPI.org